Research

Mixed

Sub-clinical gut microbiome dysbiosis, characterized by decreased Akkermansia muciniphila and increased oxidative stress resistance pathways, serves as an early biomarker for obesity and type 2 diabetes prior to clinical onset.

This research suggests that gut health changes occur before blood sugar or weight issues become clinically apparent. Monitoring gut health markers like Akkermansia levels could potentially offer early warnings for metabolic health risks, allowing for proactive lifestyle adjustments.

ModerateSupportsMEDIUM confidence
We found changes both in composition and in function of the sub-clinical gut microbiome, including a decrease in Akkermansia muciniphila suggesting a role prior to the onset of disease, and functional changes reflecting a response to oxidative stress comparable to that previously observed in chronic T2D and inflammatory bowel diseases.
Moran Yassour et al. · Genome Medicine · 2016

Why this rating

Observational cohort study with strong genetic controls (twins) but small sample size (n=20 pairs).

Source

Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes

Moran Yassour et al. · Genome Medicine · 2016

DOI 10.1186/s13073-016-0271-6

cohort · n=20Cited 288×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →